Table 1.
Characteristics of eligible patients (n = 63)
| n | % | |
|---|---|---|
| Age at study entry (years) | ||
| Median: 57 | ||
| Range: 31–76 | ||
| Gender | ||
| Male | 49 | 78 |
| Female | 14 | 22 |
| Race | ||
| White | 56 | 89 |
| Black | 7 | 11 |
| ECOG performance status | ||
| 0 | 39 | 62 |
| 1 | 24 | 38 |
| Smoking history | ||
| Never smoked | 14 | 24 |
| Cigarette smoker (pack years) | ||
| <20 | 10 | 18 |
| 20–40 | 17 | 29 |
| >40 | 17 | 29 |
| Unknown/other | 5 | — |
| Cancer stage | ||
| Stage III | 21 | 33 |
| Stage IV | 42 | 67 |
| Tumor stage (Clinical) | ||
| T1–2 | 22 | 35 |
| T3–4 | 41 | 65 |
| Primary site | ||
| Oral–oral cavity | 3 | 5 |
| Oropharynx, NOS | 7 | 11 |
| Tonsillar fossa, tonsil | 13 | 21 |
| Posterior pharyngeal wall | 3 | 5 |
| Base of tongue | 12 | 19 |
| Hypopharynx, NOS | 4 | 6 |
| Pyriform fossa | 3 | 5 |
| Larynx, NOS | 6 | 9 |
| Supraglottic larynx | 7 | 11 |
| Glottic larynx | 2 | 3 |
| >1 primary site | 3 | 5 |